Processing

Please wait...

Settings

Settings

Goto Application

1. WO2020089147 - AMORPHOUS COMPOUNDS OF FORMULA (I) AND AMORPHOUS COMPOUNDS OF FORMULA (I) SALTS

Publication Number WO/2020/089147
Publication Date 07.05.2020
International Application No. PCT/EP2019/079350
International Filing Date 28.10.2019
IPC
C07D 241/04 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
241Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
02not condensed with other rings
04having no double bonds between ring members or between ring members and non-ring members
A61K 31/495 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
495having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
A61P 25/18 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
CPC
A61P 25/18
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
C07D 241/04
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
241Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
02not condensed with other rings
04having no double bonds between ring members or between ring members and non-ring members
Applicants
  • H. LUNDBECK A/S [DK]/[DK]
Inventors
  • KATEB, Jens
  • KNAPP, Matthias, Manne
Priority Data
PA20180078329.10.2018DK
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) AMORPHOUS COMPOUNDS OF FORMULA (I) AND AMORPHOUS COMPOUNDS OF FORMULA (I) SALTS
(FR) COMPOSÉS AMORPHES DE FORMULE (I) ET SELS DE COMPOSÉS AMORPHES DE FORMULE (I)
Abstract
(EN)
The present invention relates to compositions comprising amorphous compounds of Formula (I) or amorphous compounds of Formula (I) salts and to processes for obtaining these. In particular, the invention relates to compositions comprising amorphous compounds of Formula (I) hydrogen fumarate and to processes for obtaining this. Further, the invention also relates to compositions comprising amorphous base of compounds of Formula (I) and to processes for obtaining this. The invention also relates to pharmaceutical compositions comprising amorphous compounds of Formula (I) or amorphous compounds of Formula (I) salts for treatment of psychiatric disorders such as schizophrenia, including Treatment Resistant Schizophrenia (TRS).
(FR)
La présente invention concerne des compositions comprenant des composés amorphes de formule (I) ou des sels de composés amorphes de formule (I) et des procédés d'obtention de ceux-ci. En particulier, l'invention concerne des compositions comprenant des composés amorphes d'hydrogénofumarate de formule (I) et des procédés pour les obtenir. En outre, l'invention concerne des compositions comprenant une base amorphe de composés de formule (I) et des procédés pour les obtenir. L'invention concerne en outre des compositions pharmaceutiques comprenant des composés amorphes de formule (I) ou des sels de composés amorphes de formule (I) pour le traitement de troubles psychiatriques tels que la schizophrénie, y compris la schizophrénie résistante au traitement (TRS).
Latest bibliographic data on file with the International Bureau